INNPF Stock Innocan Pharma (INNPF, $18.86) was a top weekly gainer, with a +5.36% jump

GET DAILY SIGNALS

Get AI intraday signals

INNPF - Innocan Pharma Corp.

Loading...

Price: $18.86

Daily change: +$0.46 (+2.5%)

Daily volume: 12.4K

Weekly price change: +$0.96 (+5.36%)

Capitalization: $51.6M

Industry: Pharmaceuticals: Other

INNPF in -0.56% downward trend, declining for three consecutive days on June 30, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where INNPF declined for three days, in of 76 cases, the price declined further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 17, 2025. You may want to consider a long position or call options on INNPF as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INNPF just turned positive on July 18, 2025. Looking at past instances where INNPF's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

INNPF moved above its 50-day moving average on July 17, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for INNPF crossed bullishly above the 50-day moving average on July 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INNPF advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

INNPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 73 cases where INNPF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.406) is normal, around the industry mean (62.701). P/E Ratio (0.000) is within average values for comparable stocks, (88.783). INNPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.074) settles around the average of (0.122) among similar stocks. INNPF's P/S Ratio (208.333) is very high in comparison to the industry average of (18.372).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INNPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INNPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.